Bio-Reference Laboratories, Inc. 

(Public, NASDAQ:BRLI)   Watch this stock   
Find more results for BRLI
Feb 8, 2010
UBS Global Healthcare Services Conference - Webcast
Jan 25, 2010
Jefferies Global Healthcare Services Conference
Dec 17, 2009
Q4 2009 Earnings Conference Call - Webcast
Dec 17, 2009
Q4 and Fiscal Year End 2009 Earnings Conference Call
More events from AOL Finance »    

Key stats and ratios

Q4 (Oct '09) 2009
Net profit margin 7.02% 6.03%
Operating margin 12.72% 10.57%
EBITD margin - 13.26%
Return on average assets 15.12% 11.85%
Return on average equity 23.86% 19.33%
Employees 1,691 -

Address

481 Edward H. Ross Drive
Elmwood Park, NJ 07407
United States - Map
+1-201-7912600 (Phone)
+1-201-7911941 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com
Discussion Group - Google Finance

Description

Bio-Reference Laboratories, Inc. (Bio-Reference) is principally engaged in providing laboratory testing services, primarily to customers in the greater New York metropolitan area, as well as to customers in a number of other states. The Company offers a list of chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology services, serology, radio-immuno analysis, toxicology (including drug screening), pap smears, tissue pathology (biopsies) and other tissue analysis. It operates two clinical laboratories, one in Elmwood Park, New Jersey and one in Valley Cottage, New York. The Company also operates an andrology laboratory in New York City; a cytogenetics testing laboratory located in Milford, Massachusetts; a pathology laboratory in Poughkeepsie, New York; a pathology laboratory in Clarksburg, Maryland, and a genetics laboratory in Gaithersburg, Maryland.

Officers and directors

Marc D. Grodman M.D.
Chairman of the Board, President, Chief Executive Officer
Age: 58
Bio & Compensation - Reuters
Sam Singer
Chief Financial Officer, Vice President, Chief Accounting Officer, Director
Age: 66
Bio & Compensation - Reuters
Howard Dubinett
Chief Operating Officer, Executive Vice President, Director
Age: 58
Bio & Compensation - Reuters
John Roglieri M.D.
Director
Age: 70
Bio & Compensation - Reuters
Gary Lederman Esq.
Director
Age: 75
Bio & Compensation - Reuters
Harry Elias
Director
Age: 79
Bio & Compensation - Reuters
Joseph Benincasa
Director
Age: 60
Bio & Compensation - Reuters